Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

OneMedNet (ONMD) Net Income towards Common Stockholders (2022 - 2025)

Historic Net Income towards Common Stockholders for OneMedNet (ONMD) over the last 4 years, with Q3 2025 value amounting to -$741000.0.

  • OneMedNet's Net Income towards Common Stockholders rose 6399.42% to -$741000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.9 million, marking a year-over-year increase of 6807.73%. This contributed to the annual value of -$10.1 million for FY2024, which is 7007.24% up from last year.
  • OneMedNet's Net Income towards Common Stockholders amounted to -$741000.0 in Q3 2025, which was up 6399.42% from $2.8 million recorded in Q2 2025.
  • In the past 5 years, OneMedNet's Net Income towards Common Stockholders ranged from a high of $2.8 million in Q2 2025 and a low of -$33.5 million during Q4 2022
  • In the last 4 years, OneMedNet's Net Income towards Common Stockholders had a median value of -$1.4 million in 2023 and averaged -$3.0 million.
  • Its Net Income towards Common Stockholders has fluctuated over the past 5 years, first plummeted by 6948123.3% in 2024, then surged by 17706.88% in 2025.
  • Over the past 4 years, OneMedNet's Net Income towards Common Stockholders (Quarter) stood at -$33.5 million in 2022, then soared by 95.89% to -$1.4 million in 2023, then plummeted by 95.95% to -$2.7 million in 2024, then skyrocketed by 72.51% to -$741000.0 in 2025.
  • Its Net Income towards Common Stockholders stands at -$741000.0 for Q3 2025, versus $2.8 million for Q2 2025 and -$2.3 million for Q1 2025.